Crossmark

NC-6004 Phase I study in combination with gemcitabine for advanced solid tumors and population PK/PD analysis

Crossref DOI link: https://doi.org/10.1007/s00280-017-3254-4

Published Online: 2017-02-21

Published Print: 2017-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Doi, Toshihiko

Hamaguchi, Tetsuya

Shitara, Kohei

Iwasa, Satoru

Shimada, Yasuhiro

Harada, Mitsunori

Naito, Kenichiro

Hayashi, Naoto

Masada, Atsuhiro https://orcid.org/0000-0002-6158-9459
Ohtsu, Atsushi
Funding

Funding for this research was provided by:

NanoCarrier Co., Ltd
License Information

License valid from 2017-02-21